Search company, investor...

Founded Year



Incubator/Accelerator | Alive

Total Raised


About Second Nature

Second Nature operates as a healthcare technology company. It provides a six-week program offering diet recommendations and helps its patient lose weight to prevent developing type 2 diabetes. The company was formerly known as OurPath. It was founded in 2015 and is based in London, United Kingdom.

Headquarters Location

483 Green Lanes

London, England, N13 4BS,

United Kingdom



Research containing Second Nature

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Second Nature in 1 CB Insights research brief, most recently on Sep 3, 2021.

Expert Collections containing Second Nature

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Second Nature is included in 4 Expert Collections, including Beauty & Personal Care.


Beauty & Personal Care

858 items

These startups aim to provide health treatments, diagnosis tools, and products that do not require a prescription or connection with a health professional to enhance personal wellbeing. This includes supplements, women's health maintenance, OTC medicines, and more.


Digital Health

10,585 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.



2,856 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.


Precision Medicine Tech Market Map

160 items

This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.

Latest Second Nature News

NICE approves four digital services for easier access to weight management support

Aug 16, 2023

The National Institute for Health and Care Excellence (NICE) has approved four digital programmes that can be used to help the NHS deliver specialist weight management services to support the use of medication in England, according to the latest draft guidance. People being referred to these services will meet the criteria for accessing weight management medication: they have at least one weight-related comorbidity such as diabetes or high blood and a body mass index (BMI) of at least 35.0kg/m2 or at a lower threshold in certain circumstances. Patients will have a clinical assessment before starting treatment and a team of specialists will provide care virtually using the platforms Liva, Oviva, Roczen or Second Nature via an app or computer. The platforms include support from a multidisciplinary team of healthcare professionals, including psychological support and monitoring to reduce the risk of harm, such as from eating disorders and mental health issues. “Traditional face to face services treating people living with obesity are unable to keep up with demand. Waiting lists are long, some areas don’t have a service, and patients need a solution” said Mark Chapman, interim director of medical technology and digital evaluation at NICE. “These four platforms could provide an option to accessing weight management support to those people who live in an area with no specialist weight management services or for those who are on a waiting list and are happy to be treated safely outside a hospital setting. By using these platforms over the next four years, NICE can learn from the evidence generated to ensure that when we carry out a full assessment, we can ensure that we are balancing delivering the best care and getting value for money for the taxpayer.” Some of the digital programmes include the ability to prescribe weight management medication such as semaglutide (Wegovy, Novo Nordisk) or liraglutide (Saxenda, Novo Nordisk), to people who are eligible. The medications must be delivered alongside a package of care alongside a reduced-calorie diet and increased physical activity in adults. Other programmes can collect and share data about weight medication use with an NHS team to support weight-management medication prescribing, as well as providing the same wraparound service involving diet and exercise. Clinical experts told the independent NICE committee there is an unequal distribution of these specialist services in England, with some people living in areas where there is no service at all and a long waiting list to be seen. The ability to use digital enabled services will also help those who cannot or do not wish to travel for appointments, and those who are happy to be treated virtually. “Technology is transforming healthcare and helping to cut NHS waiting times – one of the government’s five priorities. The use of apps in weight management services will improve access to support that, alongside life-changing drugs, can help tackle obesity – which costs the NHS billions every year and is the second biggest cause of cancer,” said Health and Social Care Secretary, Steve Barclay. “The newest obesity medicines have the potential to help patients lose significant amounts of weight and reduce related conditions, but it’s vital they are used alongside diet, physical activity, and wider behavioural support to help stop people regaining weight.” In the 2021 Health Survey for England, published by NHS Digital, 25.9% of adults in England were living with obesity and a further 37.9% were overweight. Over the next four-years, evidence will be generated on their long-term cost effectiveness. Early results from the economic modelling show that the technologies could be cost effective, but the results are uncertain. An independent NICE committee will review the evidence generated after this period and produce new guidance. Calculations by NICE show that up to 48,000 people would be able to access the virtual services and if all those eligible enrolled up to 145,000 hours of clinician time would be saved. Early evidence suggests that weight loss of those using these digital platforms is similar at 2 years, compared with face-to-face specialist weight management services. Liva is available to be deployed into use by the NHS while Oviva, Roczen and Second Nature can be used once they have appropriate Digital Technology Assessment Criteria approval from NHS England. A consultation on the recommendations have now begun via and comments must be submitted by Friday 25 August 2023.

Second Nature Frequently Asked Questions (FAQ)

  • When was Second Nature founded?

    Second Nature was founded in 2015.

  • Where is Second Nature's headquarters?

    Second Nature's headquarters is located at 483 Green Lanes, London.

  • What is Second Nature's latest funding round?

    Second Nature's latest funding round is Incubator/Accelerator.

  • How much did Second Nature raise?

    Second Nature raised a total of $13.64M.

  • Who are the investors of Second Nature?

    Investors of Second Nature include Plug and Play Insurtech, Speedinvest, Bethnal Green Ventures, Taavet Hinrikus, Connect Ventures and 7 more.

  • Who are Second Nature's competitors?

    Competitors of Second Nature include Liva Healthcare and 7 more.


Compare Second Nature to Competitors

Omada Health Logo
Omada Health

Omada Health operates as a digital behavioral medicine company. The company helps to protect patients from chronic conditions like heart disease and type two diabetes. It offers behavioral counseling by using insights about social networking, gaming, and behavioral sciences. It primarily serves sectors such as employers, health plans, benefit consultants, and health systems & providers. Omada Health serves the It was founded in 2011 and is based in San Francisco, California.

Noom Logo

Noom operates as a behavior change company in the healthcare and weight loss industries. The company offers services that leverage artificial intelligence, mobile technology, and psychology to help individuals adopt healthier long-term habits. Its primary customer base includes healthcare and pharmaceutical companies seeking to improve patient outcomes. It was formerly known as WorkSmart Labs. It was founded in 2008 and is based in New York, New York.

Oviva Logo

Oviva offers personalized dietary advice through its digital application to help individuals make targeted dietary changes to improve their health. It primarily serves the healthcare industry, partnering with health insurers, healthcare systems, and doctors to provide accessible care. It was founded in 2013 and is based in Zurich, Switzerland.

Liva Healthcare Logo
Liva Healthcare

Liva Healthcare is a digital health coaching company. It provides personalized health coaching to help people prevent and overcome obesity, type 2 diabetes, and cardiovascular diseases. It was founded in 2015 and is based in Copenhagen, Denmark.

The Clear Health Program

The Clear Health Program is a health-focused company operating in the healthcare industry. The company offers a treatment program that uses nutrition to help manage and potentially reverse Type 2 diabetes. The program includes a mobile application and coaching, and it primarily targets individuals with Type 2 diabetes. It was founded in 2019 and is based in Amsterdam, Netherlands.

Vida Health Logo
Vida Health

Vida Health provides personalized health coaching and programs in the healthcare sector. The company offers services for managing chronic conditions such as diabetes, obesity, depression, and hypertension through a combination of human-led care and technology. Vida Health primarily sells to employers and health plans, providing solutions to support employee benefits and physical and mental health care. It was founded in 2014 and is based in San Francisco, California.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.